About GE Healthcare Technologies, Inc. 
GE Healthcare Technologies, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 148 Schemes (42.76%)
Foreign Institutions
Held by 447 Foreign Institutions (19.22%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
5,131 Million
(Quarterly Results - Mar 2026)
Net Profit:
411 Million
Pharmaceuticals & Biotechnology
USD 32,891 Million (Mid Cap)
15.00
NA
0.10%
0.54
20.79%
3.17






